Matthew Suderman is an Associate Professor in Molecular Epidemiology in the Integrative Epidemiology Unit at the University of Bristol.
He has a PhD in Computer Science from McGill University, and he has spent the following 15 years investigating the relationship of the epigenome to exposure and phenotype in human populations and model organisms. The aim of this research is to use the epigenome to predict disease risk, prognosis and response to therapy.
